Bayer CropScience

Seeds, Traits And Biofuels Will Unlock New Value Pools

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

18 May 25

Updated

07 Dec 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-29.5%

-1.0%

-29.5%

-1.0%

You can edit this narrative until Dec 8 12:10 PM. Then, changes will post as Updates.

Author's Valuation

₹5.28k16.9% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates2

Shared on 07 Dec 25

Fair value Decreased 4.94%

506285: Interim Dividend Decision Will Drive Bullish Sentiment Into 2025

Narrative Update on Bayer CropScience Analysts have trimmed their price target for Bayer CropScience by approximately EUR 275, reflecting slightly softer expectations for revenue growth and profit margins, even as long term valuation multiples remain supportive. What's in the News A board meeting is scheduled for November 7, 2025 to review the unaudited financial results for the quarter ended September 30, 2025.

Shared on 23 Nov 25

Fair value Decreased 6.44%

506285: Interim Dividend Consideration Will Drive Bullish Momentum Into 2025

Narrative Update on Bayer CropScience Analysts have lowered their fair value estimate for Bayer CropScience from €5,939 to €5,556. They attribute this reduction to a slightly lower projected profit margin, which outweighs improvements in expected revenue growth and a modest decrease in the discount rate.

AnalystConsensusTarget Fair Value

₹5.28k

16.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

8.95%

Chemicals revenue growth rate

0.61%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

13.35%

Calculation

₹9.24b

Earnings '28

36.63x

PE Ratio '28

₹338.40b

Market Cap '28

₹338.40b

Market Cap '28

44.93m

No. shares '28

₹7.53k

Share Price '28

₹7.53k Share Price '28

Discounted to 2025 @ 13.34% p.a.

₹5.17k

Fair Value '25